Disclosed is the use of flibanserin, for the preparation of a medicament for the treatment of postmenopausal Sexual Desire Disorders (lifelong or acquired) in women, wherein the medicament contains flibanserin as the only pharmaceutically active ingredient and wherein the medicament is adapted for administration once daily consecutively over a period of time.
